Viewing Study NCT01446133


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-03-07 @ 11:47 PM
Study NCT ID: NCT01446133
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-07
First Post: 2011-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module